13F filing recap · Q4 2018

What did Engaged Capital buy in Q4 2018?

Reported stock-position changes between this filing and the previous one.

Stock value

$539.33M

Positions

Estimated turnover

15.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

DFRGDelaware Frisco'S Restaurant Group, Inc.$23.80Mreported value+3.33M shares MGLNMagellan Health Inc$14.55Mreported value+255.8K shares

Increased positions

UPBDUpbound Group, Inc$86.35Mreported value+800.0K shares+17.6%APOGApogee Enterprises, Inc.$50.43Mreported value+198.3K shares+13.3%INWKInnerworkings Inc$9.66Mreported value+877.7K shares+51.5%

Reduced positions

BHEBenchmark Electronics, Inc.$47.38Mreported value-32.0K shares-1.4%VYXNcr Voyix Corporation$24.84Mreported value-2.6K shares-0.2%PETXAratana Therapeutics Inc$21.38Mreported value-577.9K shares-14.2%ANIKAnika Therapeutics, Inc.$12.60Mreported value-12.0K shares

Exited positions

CLSCelestica Inc.$15.65Mprior reported value-1.44M shares-100.0%UEICUniversal Electronics Inc.$7.55Mprior reported value-191.8K shares-100.0%PBYIPuma Biotechnology, Inc.$6.96Mprior reported value-151.7K shares-100.0%